The North America Extremity Reconstruction Market is expected to witness market growth of 5.8% CAGR during the forecast period (2022-2028).
The market for extremity reconstruction devices is divided into two categories: lower extremity reconstruction devices and upper extremity reconstruction devices. To combat the weak market growth, top corporations have expanded their attention to the upper extremity divisions. The demand for reconstructive surgery is growing as the number of accidents, deformities, and congenital anomalies in the upper and lower extremities of the human body rise. Implant devices for the wrist, shoulder, digits, ankle joints, elbow, and foot make up the extremities reconstruction industry. The expansion of the extremity reconstruction market is mostly driven by the ageing population. For instance, the number of people affected by arthritis in the United States is expected to rise to 78 million by 2040, as per the Centers for Disease Control and Prevention, due to an ageing population.
Plastic surgeons are frequently engaged, and it should be conversant with lower extremity reconstruction techniques. Lower extremity abnormalities are commonly caused by a high-energy trauma or following ablative tumor removal. This is because of the bigger mass and high vascularity of available local soft tissues, thigh defects are less problematic.
In the United States, among many kind of disease and injuries, breast cancer is the second most frequent cancer among women (some types of skin cancer are the most common). The annual rate of new female breast cancer cases was 128.3 per 100,000 women. The annual death rate for women was 19.9 per 100,000. The rates are age-adjusted and based on cases and deaths from 2015 to 2019. For instance, according to 2017-2019 estimates, 12.9 percent of women is expected to be diagnosed with female breast cancer at a certain point in their lives. In 2019, a projected 3,771,795 women in the United States were diagnosed with female breast cancer.
Extremity reconstruction devices are highly beneficial in terms of treating breast cancer and similar diseases with wide range of tools and devices. Breast cancer is a modern American pandemic that affects one in every eight women in the United States. In addition, breast cancer incidence has increased considerably during the previous four decades. Additionally, an increase in the breast cancer rates has been linked to greater international acceptability of Western-style sexual and reproductive practices.
The US market dominated the North America Extremity Reconstruction Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $1,453.9 Million by 2028. The Canada market is estimated to grow at a CAGR of 8.2% during (2022 - 2028). Additionally, The Mexico market is expected to witness a CAGR of 7.2% during (2022 - 2028).
Based on Material, the market is segmented into Metallic, Ceramic, Polymeric, and Natural. Based on Product, the market is segmented into Upper Extremity and Lower Extremity. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), Integra LifeSciences Holdings Corporation, Medtronic PLC, ConMed Corporation, Acumed LLC, Skeletal Dynamics, LLC, Arthrex, Inc., and IDS GeoRadar s.r.l.(Hexagon AB)
The market for extremity reconstruction devices is divided into two categories: lower extremity reconstruction devices and upper extremity reconstruction devices. To combat the weak market growth, top corporations have expanded their attention to the upper extremity divisions. The demand for reconstructive surgery is growing as the number of accidents, deformities, and congenital anomalies in the upper and lower extremities of the human body rise. Implant devices for the wrist, shoulder, digits, ankle joints, elbow, and foot make up the extremities reconstruction industry. The expansion of the extremity reconstruction market is mostly driven by the ageing population. For instance, the number of people affected by arthritis in the United States is expected to rise to 78 million by 2040, as per the Centers for Disease Control and Prevention, due to an ageing population.
Plastic surgeons are frequently engaged, and it should be conversant with lower extremity reconstruction techniques. Lower extremity abnormalities are commonly caused by a high-energy trauma or following ablative tumor removal. This is because of the bigger mass and high vascularity of available local soft tissues, thigh defects are less problematic.
In the United States, among many kind of disease and injuries, breast cancer is the second most frequent cancer among women (some types of skin cancer are the most common). The annual rate of new female breast cancer cases was 128.3 per 100,000 women. The annual death rate for women was 19.9 per 100,000. The rates are age-adjusted and based on cases and deaths from 2015 to 2019. For instance, according to 2017-2019 estimates, 12.9 percent of women is expected to be diagnosed with female breast cancer at a certain point in their lives. In 2019, a projected 3,771,795 women in the United States were diagnosed with female breast cancer.
Extremity reconstruction devices are highly beneficial in terms of treating breast cancer and similar diseases with wide range of tools and devices. Breast cancer is a modern American pandemic that affects one in every eight women in the United States. In addition, breast cancer incidence has increased considerably during the previous four decades. Additionally, an increase in the breast cancer rates has been linked to greater international acceptability of Western-style sexual and reproductive practices.
The US market dominated the North America Extremity Reconstruction Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $1,453.9 Million by 2028. The Canada market is estimated to grow at a CAGR of 8.2% during (2022 - 2028). Additionally, The Mexico market is expected to witness a CAGR of 7.2% during (2022 - 2028).
Based on Material, the market is segmented into Metallic, Ceramic, Polymeric, and Natural. Based on Product, the market is segmented into Upper Extremity and Lower Extremity. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), Integra LifeSciences Holdings Corporation, Medtronic PLC, ConMed Corporation, Acumed LLC, Skeletal Dynamics, LLC, Arthrex, Inc., and IDS GeoRadar s.r.l.(Hexagon AB)
Scope of the Study
Market Segments Covered in the Report:
By Material
- Metallic
- Ceramic
- Polymeric
- Natural
By Product
- Upper Extremity
- Lower Extremity
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Smith & Nephew PLC
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Johnson & Johnson (DePuy Synthes)
- Integra LifeSciences Holdings Corporation
- Medtronic PLC
- ConMed Corporation
- Acumed LLC
- Skeletal Dynamics, LLC
- Arthrex, Inc
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. North America Extremity Reconstruction Market by Material
Chapter 5. North America Extremity Reconstruction Market by Product
Chapter 6. North America Extremity Reconstruction Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Smith & Nephew PLC
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Johnson & Johnson (DePuy Synthes)
- Integra LifeSciences Holdings Corporation
- Medtronic PLC
- ConMed Corporation
- Acumed LLC
- Skeletal Dynamics, LLC
- Arthrex, Inc.
Methodology
LOADING...
